Concert Pharmaceuticals Inc. (CNCE)

After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).

EJF Capital, which saw substantial losses amid the coronavirus-related selloff in March, is raising capital for a fund that seeks to take advantage of fresh opportunities it sees in the unsettled financial...

Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018.

Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through October 17th.

Concerns over rising interest rates and expected further rate increases have hit several stocks hard since the end of the third quarter.

One Wall Street analyst abruptly changed his view for Facebook shares within hours after seeing a big drop in the internet giant's stock price.

The final six months 2015, and pretty much the entirety of 2016, proved a tough period for the majority of biotechnology companies.

A whopping number of 13F filings filed with U.S.